Pidnarulex
- Generic Name
- Pidnarulex
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C27H27N7O2S
- CAS Number
- 1138549-36-6
- Unique Ingredient Identifier
- 3R4C5YLB9I
- Associated Conditions
- -
- Associated Therapies
- -
Senhwa Biosciences Presents Clinical Data Abstract on Pidnarulex at 2024 ESMO Congress
Pidnarulex (CX-5461) showed acceptable tolerability and preliminary efficacy in Phase Ib study, with 40% of evaluable end-stage oncology patients achieving clinical benefit, including stable disease (SD) in those previously resistant to PARP inhibitors.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath